Nettet24. aug. 2024 · POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally … Nettet18. sep. 2024 · POD1UM-303/InterAACT 2 (NCT04472429), a Phase 3 trial of retifanlimab in combination with carboplatin and paclitaxel in patients with inoperable locally recurrent or metastatic SCAC is now open ...
INTERACT-2 Stroke
Nettet29. aug. 2013 · The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke. 2013; 44:620–626. Link Google Scholar; 2. Kidwell CS, Saver JL, Mattiello J, … Nettet29. mai 2013 · Trial Design INTERACT2 was an international, multicenter, prospective, randomized, open-treatment, blinded end-point trial. Details of the design have been … craftsman 87702 download
The Role of Immunotherapy in the Treatment of Anal Cancer and …
Nettet“InterAAct was an international trial comparing carboplatin-paclitaxel and cisplatin plus 5-flourouracil,” Eng said. “Carboplatin-paclitaxel was associated with less toxicity and a trend towards improved survival, which suggests that it should become the standard of care for these patients and the backbone for future phase 3 trials.” Nettet12. sep. 2016 · The trial results showed that intensive blood pressure lowering did not reduce the risk of death or severe disability. The Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II is an ongoing trial with a similar clinical question to the INTERACT. The trial is expected to be completed in 2016. Guidelines NettetInterAACT is a randomised, multicentre Phase II trial. Eligible participants will be randomly allocated to one of the two groups. One group (approximately half of the … division by 4 in binary system